Xiangyang Yao

1.3k total citations · 1 hit paper
24 papers, 958 citations indexed

About

Xiangyang Yao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Xiangyang Yao has authored 24 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Xiangyang Yao's work include RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Xiangyang Yao is often cited by papers focused on RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Xiangyang Yao collaborates with scholars based in China, United States and India. Xiangyang Yao's co-authors include Jing Luo, Fengjing Guo, Jing Xiong, Kai Sun, Guilan Li, Hui Xu, Haoran Liu, Hua Xu, Zhimin Yin and Chen Duan and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

Xiangyang Yao

22 papers receiving 942 citations

Hit Papers

The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a ... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyang Yao China 13 504 232 162 140 119 24 958
Yuyu Liu China 19 634 1.3× 108 0.5× 115 0.7× 113 0.8× 92 0.8× 72 1.2k
Aranka Brockmueller Germany 19 530 1.1× 131 0.6× 122 0.8× 206 1.5× 59 0.5× 33 1.1k
Young Mi Kim South Korea 24 623 1.2× 177 0.8× 120 0.7× 117 0.8× 51 0.4× 67 1.6k
Nazir M. Khan United States 22 790 1.6× 532 2.3× 314 1.9× 199 1.4× 143 1.2× 44 1.4k
Nashrah Ahmad United States 7 332 0.7× 381 1.6× 190 1.2× 100 0.7× 47 0.4× 12 874
Priyanka Kushwaha India 23 855 1.7× 93 0.4× 189 1.2× 177 1.3× 78 0.7× 54 1.5k
Gaofeng Zeng China 21 578 1.1× 52 0.2× 99 0.6× 161 1.1× 201 1.7× 58 1.2k
Yong Jin China 23 720 1.4× 140 0.6× 53 0.3× 264 1.9× 91 0.8× 56 1.4k
Te-Mao Li Taiwan 18 394 0.8× 53 0.2× 109 0.7× 117 0.8× 69 0.6× 20 877
Zhigang Zhang China 17 717 1.4× 84 0.4× 73 0.5× 135 1.0× 85 0.7× 64 1.5k

Countries citing papers authored by Xiangyang Yao

Since Specialization
Citations

This map shows the geographic impact of Xiangyang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Yao more than expected).

Fields of papers citing papers by Xiangyang Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Yao. The network helps show where Xiangyang Yao may publish in the future.

Co-authorship network of co-authors of Xiangyang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Yao. A scholar is included among the top collaborators of Xiangyang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Yao. Xiangyang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bo, Haoran Liu, Yangjun Zhang, et al.. (2024). Sirtuin1 Suppresses Calcium Oxalate Nephropathy via Inhibition of Renal Proximal Tubular Cell Ferroptosis Through PGC‐1α‐mediated Transcriptional Coactivation. Advanced Science. 11(48). e2408945–e2408945. 9 indexed citations
2.
Wu, Xiaoliang, Ruixin Fan, Yangjun Zhang, et al.. (2024). The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment. Clinical and Experimental Medicine. 24(1). 191–191. 1 indexed citations
3.
Wu, Xiaoliang, Guoliang Sun, Ruixin Fan, et al.. (2024). CircSP3 encodes SP3-461aa to promote ccRCC progression via stabilizing MYH9 and activating the PI3K-Akt signaling pathway. Journal of Cancer. 15(18). 5876–5896. 1 indexed citations
4.
Zhang, Yangjun, Zhenzhen Xu, Bo Li, et al.. (2024). OncoSplicing 3.0: an updated database for identifying RBPs regulating alternative splicing events in cancers. Nucleic Acids Research. 53(D1). D1460–D1466.
5.
Duan, Chen, Yangjun Zhang, Lu Li, et al.. (2023). Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors. Frontiers in Oncology. 13. 1249932–1249932. 2 indexed citations
6.
Yao, Xiangyang, Hui Zhou, Chen Duan, et al.. (2023). Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing. Frontiers in Immunology. 13. 1096494–1096494. 8 indexed citations
7.
Xu, Zhenzhen, Xiangyang Yao, Chen Duan, Haoran Liu, & Hua Xu. (2023). Metabolic changes in kidney stone disease. Frontiers in Immunology. 14. 1142207–1142207. 33 indexed citations
8.
Huang, Yuxuan, Xiangyang Yao, Xianzhong Huang, et al.. (2022). Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen, China. Frontiers in Public Health. 10. 1038017–1038017. 2 indexed citations
9.
Lv, Peng, Haoran Liu, Tao Ye, et al.. (2021). XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis‐Induced Renal Inflammation and Oxidative Injury via the miR‐223/NLRP3 Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 1676152–1676152. 32 indexed citations
10.
Yao, Xiangyang, Haoran Liu, & Hua Xu. (2021). The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta‐Analysis. BioMed Research International. 2021(1). 5311828–5311828. 7 indexed citations
12.
Sun, Kai, et al.. (2020). The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis and Cartilage. 28(4). 400–409. 447 indexed citations breakdown →
13.
Li, Xiaojuan, Lu Huang, Yunjun Xiao, et al.. (2019). Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus. Journal of Virology. 93(10). 12 indexed citations
14.
Yao, Xiangyang, et al.. (2017). Taraxerol Induces Cell Apoptosis through A Mitochondria-Mediated Pathway in HeLa Cells.. SHILAP Revista de lepidopterología. 19(3). 512–519. 15 indexed citations
16.
Yao, Xiangyang, et al.. (2015). Solanesol protects human hepatic L02 cells from ethanol-induced oxidative injury via upregulation of HO-1 and Hsp70. Toxicology in Vitro. 29(3). 600–608. 31 indexed citations
17.
Yao, Xiangyang, et al.. (2013). Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation. International Immunopharmacology. 15(2). 316–324. 42 indexed citations
18.
Yao, Xiangyang, et al.. (2012). Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity. International Immunopharmacology. 14(2). 138–144. 20 indexed citations
19.
Li, Guilan, Yin Ye, Jingjing Kang, et al.. (2011). l-Theanine prevents alcoholic liver injury through enhancing the antioxidant capability of hepatocytes. Food and Chemical Toxicology. 50(2). 363–372. 93 indexed citations
20.
Li, Guilan, Jingjing Kang, Xiangyang Yao, et al.. (2011). The component of green tea, L-theanine protects human hepatic L02 cells from hydrogen peroxide-induced apoptosis. European Food Research and Technology. 233(3). 427–435. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026